These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8098789)

  • 1. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
    Harrison LC; Honeyman MC; DeAizpurua HJ; Schmidli RS; Colman PG; Tait BD; Cram DS
    Lancet; 1993 May; 341(8857):1365-9. PubMed ID: 8098789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes.
    Honeyman MC; Cram DS; Harrison LC
    J Exp Med; 1993 Feb; 177(2):535-40. PubMed ID: 8426122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
    Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes.
    Couper JJ; Harrison LC; Aldis JJ; Colman PG; Honeyman MC; Ferrante A
    Hum Immunol; 1998 Aug; 59(8):493-9. PubMed ID: 9712353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
    Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
    J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ; Wilson YM; Harrison LC
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
    Atkinson MA; Bowman MA; Campbell L; Darrow BL; Kaufman DL; Maclaren NK
    J Clin Invest; 1994 Nov; 94(5):2125-9. PubMed ID: 7962558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.
    Trigwell SM; Radford PM; Page SR; Loweth AC; James RF; Morgan NG; Todd I
    Clin Exp Immunol; 2001 Nov; 126(2):242-9. PubMed ID: 11703367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
    Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
    Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
    Roll U; Christie MR; Standl E; Ziegler AG
    Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.
    Atkinson MA; Kaufman DL; Newman D; Tobin AJ; Maclaren NK
    J Clin Invest; 1993 Jan; 91(1):350-6. PubMed ID: 8423231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.